SCHEMBL20182292

SCHEMBL20182292

CCC(/C(=C/Nc1ccc(F)cc1F)N=N)n1cc(-c2cnc(OC)c(F)c2)c2c(N)ncnc21

nearest known ligand 0.37

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NEK7 Q8TDX7 5/20 0.37
NTRK1 P04629 1/20 0.37
NTRK3 Q16288 1/20 0.37
NTRK2 Q16620 1/20 0.37
FLT3 P36888 6/20 0.36
EGFR P00533 3/20 0.35
ABL1 P00519 2/20 0.35
ABL2 P42684 2/20 0.35
EIF2AK3 Q9NZJ5 1/20 0.35
KDR P35968 2/20 0.34
TEK Q02763 2/20 0.34
PIK3CD O00329 1/20 0.34
PIK3CA P42336 1/20 0.34
PIK3CB P42338 1/20 0.34
PIK3CG P48736 1/20 0.34
PRKDC P78527 1/20 0.34
SRC P12931 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20182289 0.92 NTRK1 (0.36) NEK7NTRK1NTRK3NTRK2FLT3
SCHEMBL20182265 0.90 NTRK1 (0.36) NEK7NTRK1NTRK3NTRK2FLT3
SCHEMBL20182275 0.90 EGFR (0.36) NEK7FLT3EGFRABL1ABL2
SCHEMBL20182291 0.89 NTRK1 (0.38) NEK7NTRK1NTRK3NTRK2FLT3
SCHEMBL20182294 0.88 CFTR (0.40) NEK7NTRK1NTRK3NTRK2FLT3
SCHEMBL20182235 0.86 EIF2AK3 (0.34) NEK7NTRK1NTRK3NTRK2FLT3
SCHEMBL20182194 0.85 EIF2AK3 (0.36) EGFRABL1ABL2EIF2AK3KDR
SCHEMBL20182222 0.83 AXL (0.34) FLT3EGFRABL1ABL2EIF2AK3
SCHEMBL20181910 0.82 CFTR (0.38) NEK7NTRK1NTRK3NTRK2EIF2AK3
SCHEMBL20181916 0.82 CFTR (0.39) EGFRABL1ABL2EIF2AK3KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018094137-A1 PYRROLOPYRIMIDINES AS CFTR POTENTIATORS CYSTIC FIBROSIS FOUNDATION THERAPEUTICS INC. (US) 2018-05-24 WO disclosed